CRAC intermediate 1

CAS No. 1249343-86-9

CRAC intermediate 1( 5-(S)-Fluorowillardiine )

Catalog No. M26129 CAS No. 1249343-86-9

CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 31 In Stock
25MG 59 In Stock
50MG 91 In Stock
100MG 138 In Stock
200MG 206 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CRAC intermediate 1
  • Note
    Research use only, not for human use.
  • Brief Description
    CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors.
  • Description
    CRAC intermediate 1 is a key intermediate in the chemical synthesis of a series of CRAC channel inhibitors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    5-(S)-Fluorowillardiine
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    AMPA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1249343-86-9
  • Formula Weight
    223.183
  • Molecular Formula
    C10H7F2N3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 50 mg/mL (224.03 mM)
  • SMILES
    Fc1cccc(F)c1C(=O)Nc1cc[nH]n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Arai AC, Kessler M, Rogers G, Lynch G. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol Pharmacol. 2000 Oct;58(4):802-13. PubMed PMID: 10999951.
molnova catalog
related products
  • ORM-10103

    ORM-10103 is a novel potent and selective inhibitor of the Na+/Ca2+ exchanger (NCX).

  • Sipatrigine

    Sipatrigine (619C89) is an antiepileptic compound with neuroprotective activity through glutamate release, TREK ion channels, TRESK channels, sodium channels, and calcium channel inhibitors in the CNS, and can be used to study TRESK channels.

  • SNX 482

    Potent and selective, voltage-dependent R-type CaV2.3 calcium channel blocker (IC50 = 30 nM). Antinociceptive; inhibits nociceptive C-fibre and Aδ-fibre-evoked neuronal responses.